Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization

Tongqiang Li,1,2,* Qin Shi,1,2,* Jiacheng Liu,1,2,* Yingliang Wang,1,2 Chen Zhou,1,2 Chaoyang Wang,1,2 Shuguang Ju,1,2 Songjiang Huang,1,2 Chongtu Yang,1,2 Yang Chen,1,2 Yaowei Bai,1,2 Bin Xiong1,2 1Department of Radiology, Union Hospital, Tongji Medical College, Huazhong Uni...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Li T, Shi Q, Liu J, Wang Y, Zhou C, Wang C, Ju S, Huang S, Yang C, Chen Y, Bai Y, Xiong B
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/5852c3c6defc41ddbb167c0395106f11
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5852c3c6defc41ddbb167c0395106f11
record_format dspace
spelling oai:doaj.org-article:5852c3c6defc41ddbb167c0395106f112021-12-02T19:17:36ZDonafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization2253-5969https://doaj.org/article/5852c3c6defc41ddbb167c0395106f112021-12-01T00:00:00Zhttps://www.dovepress.com/donafenib-loaded-callispheres-beads-embolization-in-a-vx2-liver-tumor--peer-reviewed-fulltext-article-JHChttps://doaj.org/toc/2253-5969Tongqiang Li,1,2,* Qin Shi,1,2,* Jiacheng Liu,1,2,* Yingliang Wang,1,2 Chen Zhou,1,2 Chaoyang Wang,1,2 Shuguang Ju,1,2 Songjiang Huang,1,2 Chongtu Yang,1,2 Yang Chen,1,2 Yaowei Bai,1,2 Bin Xiong1,2 1Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of China; 2Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022, People’s Republic of China*These authors contributed equally to this workCorrespondence: Bin XiongDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue #1277, Wuhan, 430022, People’s Republic of ChinaEmail herr_xiong@126.comObjective: To investigate the efficiency and safety of callispheres beads loaded with donafenib (DCBs) for embolization in a VX2 liver tumor, as well as the improvement of tumor angiogenesis following embolization.Methods: Forty New Zealand white rabbit VX2 liver tumors were treated with four different drugs via the hepatic artery: NS (normal saline), CB (blank callispheres beads), ACB (adriamycin-loaded callispheres beads) and DCB (DCBs). Hematoxylin-eosin staining was performed to assess tumor necrosis, while MRI was employed to detect the changes in tumor size. The safety was evaluated by the liver and kidney function parameters, and the immunofluorescence and immunohistochemical staining were performed to reflect the tumor hypoxia and tumor angiogenesis following embolization.Results: The DCB group had the smallest tumor growth rate, but the tumor necrosis rate was the highest of the four groups. Compared to the CB and ACB groups, the DCB group did not aggravate the liver damage and had no influence on kidney function. The staining results showed that, although the tumor hypoxia deteriorated after DCBs embolization, the expression of VEGF (vascular endothelial growth factor) reduced, thus inhibiting tumor angiogenesis.Conclusion: DCB administration via hepatic artery is an effective and safe treatment for a preclinical liver cancer model, with the unique benefit of suppressing tumor angiogenesis following embolization.Keywords: hepatocellular carcinoma, donafenib, transcatheter arterial chemoembolization, tumor angiogenesis, efficacy, safetyLi TShi QLiu JWang YZhou CWang CJu SHuang SYang CChen YBai YXiong BDove Medical Pressarticlehepatocellular carcinomadonafenibtranscatheter arterial chemoembolizationtumor angiogenesisefficacysafety;Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal of Hepatocellular Carcinoma, Vol Volume 8, Pp 1525-1535 (2021)
institution DOAJ
collection DOAJ
language EN
topic hepatocellular carcinoma
donafenib
transcatheter arterial chemoembolization
tumor angiogenesis
efficacy
safety;
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle hepatocellular carcinoma
donafenib
transcatheter arterial chemoembolization
tumor angiogenesis
efficacy
safety;
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Li T
Shi Q
Liu J
Wang Y
Zhou C
Wang C
Ju S
Huang S
Yang C
Chen Y
Bai Y
Xiong B
Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization
description Tongqiang Li,1,2,* Qin Shi,1,2,* Jiacheng Liu,1,2,* Yingliang Wang,1,2 Chen Zhou,1,2 Chaoyang Wang,1,2 Shuguang Ju,1,2 Songjiang Huang,1,2 Chongtu Yang,1,2 Yang Chen,1,2 Yaowei Bai,1,2 Bin Xiong1,2 1Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of China; 2Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022, People’s Republic of China*These authors contributed equally to this workCorrespondence: Bin XiongDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue #1277, Wuhan, 430022, People’s Republic of ChinaEmail herr_xiong@126.comObjective: To investigate the efficiency and safety of callispheres beads loaded with donafenib (DCBs) for embolization in a VX2 liver tumor, as well as the improvement of tumor angiogenesis following embolization.Methods: Forty New Zealand white rabbit VX2 liver tumors were treated with four different drugs via the hepatic artery: NS (normal saline), CB (blank callispheres beads), ACB (adriamycin-loaded callispheres beads) and DCB (DCBs). Hematoxylin-eosin staining was performed to assess tumor necrosis, while MRI was employed to detect the changes in tumor size. The safety was evaluated by the liver and kidney function parameters, and the immunofluorescence and immunohistochemical staining were performed to reflect the tumor hypoxia and tumor angiogenesis following embolization.Results: The DCB group had the smallest tumor growth rate, but the tumor necrosis rate was the highest of the four groups. Compared to the CB and ACB groups, the DCB group did not aggravate the liver damage and had no influence on kidney function. The staining results showed that, although the tumor hypoxia deteriorated after DCBs embolization, the expression of VEGF (vascular endothelial growth factor) reduced, thus inhibiting tumor angiogenesis.Conclusion: DCB administration via hepatic artery is an effective and safe treatment for a preclinical liver cancer model, with the unique benefit of suppressing tumor angiogenesis following embolization.Keywords: hepatocellular carcinoma, donafenib, transcatheter arterial chemoembolization, tumor angiogenesis, efficacy, safety
format article
author Li T
Shi Q
Liu J
Wang Y
Zhou C
Wang C
Ju S
Huang S
Yang C
Chen Y
Bai Y
Xiong B
author_facet Li T
Shi Q
Liu J
Wang Y
Zhou C
Wang C
Ju S
Huang S
Yang C
Chen Y
Bai Y
Xiong B
author_sort Li T
title Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization
title_short Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization
title_full Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization
title_fullStr Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization
title_full_unstemmed Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization
title_sort donafenib-loaded callispheres beads embolization in a vx2 liver tumor: investigating efficacy, safety, and improvement of tumor angiogenesis after embolization
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/5852c3c6defc41ddbb167c0395106f11
work_keys_str_mv AT lit donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization
AT shiq donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization
AT liuj donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization
AT wangy donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization
AT zhouc donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization
AT wangc donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization
AT jus donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization
AT huangs donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization
AT yangc donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization
AT cheny donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization
AT baiy donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization
AT xiongb donafenibloadedcallispheresbeadsembolizationinavx2livertumorinvestigatingefficacysafetyandimprovementoftumorangiogenesisafterembolization
_version_ 1718376852248068096